This study is in progress, not accepting new patients
EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)
Summary
- Eligibility
- for people ages 18-35 (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Editas Medicine, Inc.
- ID
- NCT05444894
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 9 study participants
- Last Updated